EWEdwin H. Wintermute

Edwin H. Wintermute

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Edwin H. Wintermute has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Empowering grassroots innovation to accelerate biomedical research

    by Bastian Greshake Tzovaras, Michael Rera, Edwin H. Wintermute, Katharina Kloppenborg, Juliette Ferry-Danini, Guy Aidelberg, Rachel Aronoff, Ariel Lindner, Dusan Misevic

    The purpose of biomedicine is to serve society, yet its hierarchical and closed structure excludes many citizens from the process of innovation. We propose a collection of reforms to better integrate citizens within the research community, reimagining biomedicine as more participatory, inclusive, and responsive to societal needs.


  • Open Access

    Low-cost drug discovery with engineered E. coli reveals an anti-mycobacterial activity of benazepril

    by Nadine Bongaerts, Zainab Edoo, Ayan A. Abukar, Xiaohu Song, Sebastián Sosa Carrillo, Ariel B. Lindner, Edwin H. Wintermute

    Whole-cell screening for Mycobacterium tuberculosis ( Mtb ) inhibitors is complicated by the pathogen’s slow growth and biocontainment requirements. Here we present a synthetic biology framework for assaying Mtb drug targets in engineered E. coli . We construct Target Essential Surrogate E. coli (TESEC) in which an essential metabolic enzyme is deleted and replaced with an Mtb -derived functional analog, linking bacterial growth to the activity of the target enzyme. High throughput screening of a TESEC model for Mtb alanine racemase (ALR) revealed benazepril as a targeted inhibitor. In vitro biochemical assays indicated a noncompetitive mechanism unlike that of clinical ALR inhibitors. This is the first report of an antimicrobial activity in an approved Angiotensin Converting Enzyme (ACE) inhibitor and may explain clinical data associating use of ACE inhibitors with reduced Mtb infection risk. We establish the scalability of TESEC for drug discovery by characterizing TESEC strains for four additional targets. SIGNIFICANCE STATEMENT: The challenge of discovering new antibiotics is both scientific and economic. No simple test can determine if a given molecule will be safe and effective in real human patients. Many drug candidates must therefore be advanced for each new antibiotic that reaches the market - a risky and expensive process. In this work we use synthetic biology to engineer the common laboratory model bacterium E. coli as a tool for early stage antibiotic discovery. As a proof of concept we expressed a known tuberculosis drug target and found a novel inhibitor: benazepril. Many other drug targets could be screened similarly using the system that we describe. Because E. coli can be grown safely and cheaply, this approach may help to reduce costs and make drug discovery more accessible.

  • Open Access

    A survival model for course-course interactions in a Massive Open Online Course platform

    by Edwin H. Wintermute, Matthieu Cisel, Ariel B. Lindner

    Massive Open Online Course (MOOC) platforms incorporate large course catalogs from which individual students may register multiple courses. We performed a network-based analysis of student achievement, considering how course-course interactions may positively or negatively affect student success. Our data set included 378,000 users and 1,000,000 unique registration events in France Université Numérique (FUN), a national MOOC platform. We adapt reliability theory to model certificate completion rates with a Weibull survival function, following the intuition that students “survive” in a course for a certain time before stochastically dropping out. Course-course interactions are found to be well described by a single parameter for user engagement that can be estimated from a user’s registration profile. User engagement, in turn, correlates with certificate rates in all courses regardless of specific content. The reliability approach is shown to capture several certificate rate patterns that are overlooked by conventional regression models. User engagement emerges as a natural metric for tracking student progress across demographics and over time.


  • Open Access

    A survival model for course-course interactions in a Massive Open Online Course platform

    by Edwin H. Wintermute, Matthieu Cisel, Ariel B. Lindner

    Massive Open Online Course (MOOC) platforms incorporate large course catalogs from which individual students may register multiple courses. We performed a network-based analysis of student achievement, considering how course-course interactions may positively or negatively affect student success. Our dataset included 378,000 users and 1,000,000 unique registration events in France Universite Numerique (FUN), a national MOOC platform. We adapt reliability theory to model certificate completion rates with a Weibull survival function, following the intuition that students "survive" in a course for a certain time before stochastically dropping out. Course-course interactions are found to be well described by a single parameter for user engagement that can be estimated from a user's registration profile. User engagement, in turn, correlates with certificate rates in all courses regardless of specific content. The reliability approach is shown to capture several certificate rate patterns that are overlooked by conventional regression models. User engagement emerges as a natural metric for tracking student progress across demographics and over time.

  • The smell of us – crowdsourcing human body odor evaluation

    by Marguerite Benony, Marianne Cardon, Arnaud Ferré, Jean Coquet, Nathan Foulquier, Florian Thonier, Lucas Le Lann, Henry De Belly, Alexandre Evans, Aakriti Jain, et al.

    Human body odor is produced when sweat-secreted compounds are metabolized by bacteria present on the skin. The resulting volatile mixture is often negatively perceived, motivating the use of personal cosmetic deodorants. Yet body odor may also be positively perceived in some contexts, and is proposed to play a role in sexual attraction, kin identification and social bonding. Because only human smellers can report the hedonic qualities of body odor, their persceptions are a valualbe complement to modern GC-MS-based quantitative chemical measurements. Here we present a crowdsourcing framework that engages volunteer smellers to characterize human sweat samples. Our approach seeks to reward both the sweat donor and the smeller with a web-based graphical interface that is informative, interesting, and fun. 300 samples from 87 individual donors were scored by 93 smellers for intensity, pleasantness, and a variety of odor descriptors. Body odor intensity and pleasantness were determined to vary with age, gender, and self-reported deodorant use. Counterintuitively, deodorant use showed no effect on the perceived intensity of body odor, and was associated with a decrease in the perceived pleasantness. From these data, we determine the precision and dynamic range of the volunteer nose as a body odor evaluation instrument and estimate the scale of crowdsourcing effort that would be required to precisely quantify the public perception of body odors.


  • Open Access

    Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

    by Aude G. Bernheim, Vincent K. Libis, Ariel B. Lindner, Edwin H. Wintermute

    RNA-mediated knockdowns are widely used to control gene expression. This versatile family of techniques makes use of short RNA (sRNA) that can be synthesized with any sequence and designed to complement any gene targeted for silencing. Because sRNA constructs can be introduced to many cell types directly or using a variety of vectors, gene expression can be repressed in living cells without laborious genetic modification. The most common RNA knockdown technology, RNA interference (RNAi), makes use of the endogenous RNA-induced silencing complex (RISC) to mediate sequence recognition and cleavage of the target mRNA. Applications of this technique are therefore limited to RISC-expressing organisms, primarily eukaryotes. Recently, a new generation of RNA biotechnologists have developed alternative mechanisms for controlling gene expression through RNA, and so made possible RNA-mediated gene knockdowns in bacteria. Here we describe a method for silencing gene expression in E. coli that functionally resembles RNAi. In this system a synthetic phagemid is designed to express sRNA, which may designed to target any sequence. The expression construct is delivered to a population of E. coli cells with non-lytic M13 phage, after which it is able to stably replicate as a plasmid. Antisense recognition and silencing of the target mRNA is mediated by the Hfq protein, endogenous to E. coli. This protocol includes methods for designing the antisense sRNA, constructing the phagemid vector, packaging the phagemid into M13 bacteriophage, preparing a live cell population for infection, and performing the infection itself. The fluorescent protein mKate2 and the antibiotic resistance gene chloramphenicol acetyltransferase (CAT) are targeted to generate representative data and to quantify knockdown effectiveness.


  • Silencing of Antibiotic Resistance in E. coli with Engineered Phage Bearing Small Regulatory RNAs

    by Vincent K. Libis, Aude G. Bernheim, Clovis Basier, Sebastián Jaramillo-Riveri, Matthew Deyell, Idonnya Aghoghogbe, Iva Atanaskovic, Amel Camélia Bencherif, Marguerite Benony, Nicolas Koutsoubelis, et al.

    In response to emergent antibiotic resistance, new strategies are needed to enhance the effectiveness of existing antibiotics. Here, we describe a phagemid-delivered, RNA-mediated system capable of directly knocking down antibiotic resistance phenotypes. Small regulatory RNAs (sRNAs) were designed to specifically inhibit translation of chloramphenicol acetyltransferase and kanamycin phosphotransferase. Nonlytic phagemids coding for sRNA expression were able to infect and restore chloramphenicol and kanamycin sensitivity to populations of otherwise resistant E. coli. This modular system could easily be extended to other bacteria with resistance profiles that depend on specific transcripts.


  • Open Access

    In Situ Characterization of Mycobacterial Growth Inhibition by Lytic Enzymes Expressed in Vectorized E. coli

    by Iva Atanaskovic, Amel Camélia Bencherif, Matthew Deyell, Sebastián Jaramillo-Riveri, Marguerite Benony, Aude G. Bernheim, Vincent K. Libis, Nicolas Koutsoubelis, Yonatan Zegman, Anne C. Löchner, et al.

    The emergence of extremely drug resistant Mycobacterium tuberculosis necessitates new strategies to combat the pathogen. Engineered bacteria may serve as vectors to deliver proteins to human cells, including mycobacteria-infected macrophages. In this work, we target Mycobacterium smegmatis, a nonpathogenic tuberculosis model, with E. coli modified to express trehalose dimycolate hydrolase (TDMH), a membrane-lysing serine esterase. We show that TDMH-expressing E. coli are capable of lysing mycobacteria in vitro and at low pH. Vectorized E. coli producing TDMH were found suppress the proliferation of mycobacteria in infected macrophages.


  • Open Access

    An objective function exploiting suboptimal solutions in metabolic networks

    by Edwin H Wintermute, Tami D Lieberman, Pamela A Silver

    Flux Balance Analysis is a theoretically elegant, computationally efficient, genome-scale approach to predicting biochemical reaction fluxes. Yet FBA models exhibit persistent mathematical degeneracy that generally limits their predictive power.


  • Open Access

    A synthetic system links FeFe-hydrogenases to essential E. coli sulfur metabolism

    by Buz Barstow, Christina M Agapakis, Patrick M Boyle, Gerald Grandl, Pamela A Silver, Edwin H Wintermute

    Background: FeFe-hydrogenases are the most active class of H2-producing enzymes known in nature and may have important applications in clean H2energy production. Many potential uses are currently complicated by a crucial weakness: the active sites of all known FeFe-hydrogenases are irreversibly inactivated by O2.Results: We have developed a synthetic metabolic pathway inE. colithat links FeFe-hydrogenase activity to the production of the essential amino acid cysteine. Our design includes a complementary host strain whose endogenous redox pool is insulated from the synthetic metabolic pathway. Host viability on a selective medium requires hydrogenase expression, and moderate O2levels eliminate growth. This pathway forms the basis for a genetic selection for O2tolerance. Genetically selected hydrogenases did not show improved stability in O2and in many cases had lost H2production activity. The isolated mutations cluster significantly on charged surface residues, suggesting the evolution of binding surfaces that may accelerate hydrogenase electron transfer.Conclusions: Rational design can optimize a fully heterologous three-component pathway to provide an essential metabolic flux while remaining insulated from the endogenous redox pool. We have developed a number of convenientin vivoassays to aid in the engineering of synthetic H2metabolism. Our results also indicate a H2-independent redox activity in three different FeFe-hydrogenases, with implications for the future directed evolution of H2-activating catalysts.